Cabozantinib Impurity 30 | CAS 202917-04-2 - Request Quote
Cabozantinib Impurity 30
| SZ CAT No: | SZ-C112046 |
| CAS No | 202917-04-2 |
| Mol.F. | C17H16N2O3 |
| Mol.Wt. | 296.3 |
| Inv. Status | Under QC Approval |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Cabozantinib Impurity 30 is chemically 3-((6,7-Dimethoxyquinolin-4-yl)oxy)aniline. Cabozantinib Impurity 30 is supplied with detailed characterization data compliant with regulatory guideline. Cabozantinib Impurity 30 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Cabozantinib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 202917-04-2
Purchase 202917-04-2
Order 202917-04-2
Enquire 202917-04-2
price of 202917-04-2
202917-04-2 Supplier
202917-04-2 Manufacturer
202917-04-2 Exporter
buy high quality Cabozantinib Impurity 30
Purchase Cabozantinib Impurity 30
Cabozantinib Impurity 30 suppliers
Cabozantinib Impurity 30 manufacturers
Cabozantinib Impurity 30 price
Order Cabozantinib Impurity 30
Enquire Cabozantinib Impurity 30
Cabozantinib Impurity 30 cost
Cabozantinib Impurity 30 Supplier
Cabozantinib Impurity 30 Distributor
Cabozantinib Impurity 30 for Method Validation
Cabozantinib Reference Standard
Cabozantinib Impurity 30 for ANDA Filing
Cabozantinib Impurity 30 for Forced Degradation Studies
Cabozantinib Impurity 30 Identification Standards
Cabozantinib Impurity 30 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


